Stock Events

Stock Events

Genelink 

$0.000040
4
+$0.00+0% Thursday 20:00

Statistics

Day High
0.00001
Day Low
0.00001
52W High
0.00004
52W Low
0.00001
Volume
500
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

14NovExpected
Q4 2011
Q1 2012
Q3 2012
Q3 2012
Q1 2013
Q2 2013
Q3 2013
-0
-0
-0
-0
Expected EPS
N/A
Actual EPS
-0.002

Financials

-142.88%Profit Margin
Unprofitable
2012
2.14MRevenue
-3.05MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GNLKQ. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap24.5B
Illumina provides sequencing and array-based solutions for genetic analysis, directly competing in the genomics space with Genelink's focus on genetic personalization.
Pacific Biosciences of California
PACB
Mkt Cap434.84M
Pacific Biosciences offers long-read sequencing technologies, competing in the broader market of genetic analysis and personalized genomics.
Thermo Fisher Scientific
TMO
Mkt Cap172.66B
Thermo Fisher Scientific offers a wide range of solutions for genetic analysis and personalized medicine, making it a competitor in the life sciences sector.
Qiagen NV
QGEN
Mkt Cap7.62B
Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the genomics and personalized health space.
Bionano Genomics
BNGO
Mkt Cap13.08M
Bionano Genomics provides tools for genomic analysis, directly competing in the genetic analysis market that includes personalized genetic services.
Guardant Health
GH
Mkt Cap17.47B
Guardant Health focuses on liquid biopsies and cancer diagnostics, competing in the personalized medicine and genomics field.
Intellia Therapeutics
NTLA
Mkt Cap2.19B
Intellia Therapeutics is involved in CRISPR gene editing, a technology that has broad applications in personalized medicine, making it a competitor in the innovative genetic solutions market.
CRISPR Therapeutics
CRSP
Mkt Cap5.33B
CRISPR Therapeutics is focused on developing gene-based medicines, directly competing in the field of personalized genetic treatments and therapies.

About

GeneLink, Inc. specializes in delivering 12-gene DNA profiling services. Beyond genetic analyses, the company also provides clients with bespoke nutritional supplements tailored to individual health needs. Additionally, the firm crafts a comprehensive collection of dermatological products. Established in 1994, GeneLink, Inc. maintains its headquarters in Orlando, Florida.
Show more...
CEO
Dr. Bernard L. Kasten Jr., Ph.D., M.D.
Employees
14
Country
United States
ISIN
US36870F1075

Listings

OTC Link
US
GNLKQ

0 Comments

Share your thoughts

FAQ

What is Genelink stock price today?▼
The current price of GNLKQ is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Genelink stock price performance more closely on the chart.
What is Genelink stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Genelink stocks are traded under the ticker GNLKQ.
Is Genelink stock price growing?▼
GNLKQ stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Genelink has showed a +0% increase.
What were Genelink earnings last quarter?▼
GNLKQ earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Genelink revenue for the last year?▼
Genelink revenue for the last year amounts to 2.14M USD.
What is Genelink net income for the last year?▼
GNLKQ net income for the last year is -3.05M USD.
How many employees does Genelink have?▼
As of June 25, 2026, the company has 14 employees.
In which sector is Genelink located?▼
Genelink operates in the Health & Wellness sector.
When did Genelink complete a stock split?▼
Genelink has not had any recent stock splits.
Where is Genelink headquartered?▼
Genelink is headquartered in Orlando, United States.